Mesirow Institutional Investment Management, Inc. Catalyst Pharmaceuticals, Inc. Transaction History
Mesirow Institutional Investment Management, Inc.
- $1.27 Billion
- Q3 2024
A detailed history of Mesirow Institutional Investment Management, Inc. transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Mesirow Institutional Investment Management, Inc. holds 800,798 shares of CPRX stock, worth $17 Million. This represents 1.26% of its overall portfolio holdings.
Number of Shares
800,798
Previous 934,234
14.28%
Holding current value
$17 Million
Previous $14.5 Million
10.01%
% of portfolio
1.26%
Previous 1.32%
Shares
3 transactions
Others Institutions Holding CPRX
# of Institutions
327Shares Held
94.6MCall Options Held
19.1KPut Options Held
51.1K-
Black Rock Inc. New York, NY18.7MShares$396 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.04MShares$170 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY6.23MShares$132 Million2.3% of portfolio
-
State Street Corp Boston, MA5.69MShares$120 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.02MShares$64 Million0.01% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.18B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...